GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
Despite a more than fifty-year period after the introduction of glucocorticoids (GCs) into therapeutic practice; they have headed the list of anti-inflammatory drugs so far. The paper analyzes current views on the terminology of GCs, mechanism of action, standardization of indications for their use...
Saved in:
| Main Authors: | T. M. Reshetnyak, N. V. Seredavkina, I. S. Dydykina, E. I. Nasonov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-07-01
|
| Series: | Klinicist |
| Subjects: | |
| Online Access: | https://klinitsist.abvpress.ru/Klin/article/view/6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GLUCOCORTICOIDS IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: POSITIVE AND NEGATIVE ASPECTS
by: N. V. Seredavkina, et al.
Published: (2014-11-01) -
Possibilities and prospects for glucocorticoid withdrawal in systemic lupus erythematosus
by: S. K. Solovyev, et al.
Published: (2020-03-01) -
Glucocorticoid toxicity index in patients with systemic lupus erythematosus (preliminary data)
by: E. V. Ermolaeva, et al.
Published: (2024-02-01) -
Mineral bone density comparative assessment in patients with systemic lupus erythematosus treated and not treated with glucocorticoids
by: L A Archakova, et al.
Published: (2004-02-01) -
Clinical effects of glucocorticoid combined with Buyang Huanwu Decoction for mild and moderate systemic lupus erythematosus
by: YANG Shi-xia
Published: (2018-01-01)